share_log

先声药业(02096.HK)8月21日举行董事会会议考虑及批准中期业绩

Simcere Pharma (02096.HK) held a board of directors meeting on August 21 to consider and approve interim performance.

Gelonghui Finance ·  Aug 9 05:00

Simcere Pharma (02096.HK) announced that the board of directors meeting will be held on August 21, 2024 (Wednesday) to consider and approve the unaudited interim performance of the company and its subsidiaries for the six months ending on June 30, 2024, and to consider recommending the distribution of interim dividends (if any).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment